Invesco Nasdaq Biotechnology ETF
$21.52
(0.56%) 0.12 at
2024-12-31 16:00:00
(0.56%) ($0.12) at 2024-12-31 16:00:00
1M
6M
1Y
5Y
MAX
52-week lows/highs
$21.52
$20.14
$24.78
52-week low
52-week high
Top 10 holdings
+271
ETF AUM
$37.86M
as of 2024-12-31 16:00:00
Expense ETF ratio
0.19%
as of 2024-12-31 16:00:00
Dividend yield of the ETF
-
as of 2024-12-31 16:00:00
NAV
21.50
ETF Company
Invesco
Investment Segment
Health Care
PriceToBook
3.93
Allocations
Health Care
91.28%
Other
8.72%
View all
United States
87.88669%
United Kingdom of Great Britain and Northern Ireland
5.75039%
France
1.5675%
Germany
1.18032%
China
1.06521%
Denmark
0.82645%
Switzerland
0.4649%
Canada
0.39893%
Netherlands
0.37407%
Singapore
0.17374%
Spain
0.10857%
Ireland
0.09019%
Hong Kong
0.05809%
Belgium
0.05493%
View all
ESG score (%)
0
Prime
Compared with 30,211 companies
Minor
0-29
Low
30-39
Mid
40-49
Steady
50-59
High
60-79
Prime
80-100
View screening report
About the ETF
IBBQ was created on 2021-06-11 by Invesco. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 38.52m in AUM and 267 holdings. IBBQ tracks a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ.
Invesco Nasdaq Biotechnology ETF
